Skip to main content

BioNanomatrix Wins $397K NHGRI Grant to Develop Its Genome Sequencer

NEW YORK (GenomeWeb News) – The National Human Genome Research Institute has awarded BioNanomatrix a $397,750 research grant to develop its nanoscale whole genome imaging platform, the company said today.
 
BioNanomatrix is developing a system that allows nanoscale single molecule identification and analysis of the entire genome. The system’s ability to deliver single molecule sensitivity in a highly parallel format with minimal processing will reduce cost and time spent on extensive data and integrative analyses, the company said.
 
The NHGRI awarded the two-year Small Business Investment Research grant under the NIH BioEngineering Nanotechnology Initiative.
 
This is BioNanomatrix’s second NIH grant this year. The company received a National Cancer Institute grant in May to develop a cancer diagnostic prototype.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.